Form 8-K - Current report:
SEC Accession No. 0001654954-24-014753
Filing Date
2024-11-21
Accepted
2024-11-21 13:47:27
Documents
18
Period of Report
2024-11-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm   iXBRL 8-K 30203
2 LETTER canna_ex991.htm EX-99.1 3360
8 canna_ex991img1.jpg GRAPHIC 3507
9 canna_ex991img2.jpg GRAPHIC 4169
  Complete submission text file 0001654954-24-014753.txt   173209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA isdr-20241120.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE isdr-20241120_lab.xml EX-101.LAB 15213
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isdr-20241120_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isdr-20241120_pre.xml EX-101.PRE 9640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isdr-20241120_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 4027
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 241483454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)